Bull & Bear

Bull and Bear

Verdict: Watchlist — the bull case is concrete but already priced into 2.83× tangible book, while the bear's governance and CRE flags are early but corrosive enough to raise the cost of being wrong. Pay-to-play here is hitting the New Frontier 15-17% adjusted ROE band on stable metric definitions, not on an "adjusted" tape that has been redefined in two consecutive Q4 prints. The single tension that matters most is whether the 12.1% GAAP ROE is the real number or a transitional drag inside a 16% adjusted plan that compounds book value through buybacks. The decisive evidence is the next two quarterly prints plus year-end 2026 CRE allowance: a clean FY26 adjusted EPS over $10 with mortgage ACL flat-to-down moves this to Lean Long; another redefinition or an ACL step-up moves it to Avoid.

Bull Case

Bull's price target is $105 over a 12-18 month horizon, set at 10.6× FY26 consensus adjusted EPS of $9.88 — halfway between the current 8.2× forward and Aflac's 12× supplemental-quality multiple, reflecting partial closure of MET's quality discount as MIM scales. The primary catalyst is the December 2026 Investor Day / New Frontier annual update, where management raises the 2027-2029 adjusted-ROE band into 16-18% and provides stand-alone fee-business disclosure for MIM. The disconfirming signal is a combined NAIC RBC ratio drop below 350% in any quarter, which would slow the buyback cadence and break the per-share-EPS support the entire thesis depends on.

Bear Case

Bear's downside target is $63, roughly 22% below the current $80.91, derived by compressing forward adjusted P/E from 9.0× to 7.0× (PRU/LNC trough zone) on a haircut FY26 adjusted EPS of $9.20 — cross-checked at 1.5× book ex-AOCI ($42.18 BVPS) = $63.27. The horizon is 12-15 months, covering the FY26 earnings cycle plus the December 2026 Investor Day. The primary trigger is FY2026 adjusted EPS below $9.50 vs $9.88 consensus, accompanied by either a third Q4 redefinition or another step-change in CRE allowance (ACL up another 50%+ from $807M). The cover signal is a clean FY26 adjusted EPS print above $10.00 with stable metric definitions, sustained adjusted ROE ≥15%, and CRE allowance flat-to-down.

The Real Debate

Verdict

Watchlist. The bear carries slightly more weight today because the price embeds plan execution that has not yet cleared two clean prints on stable definitions, and 2.83× tangible book is the highest multiple MET has worn in a decade. The most important tension is whether the 15-17% adjusted ROE is earned or engineered — the gap between 16% adjusted and 12.1% GAAP ROE has widened in the same plan window where management redefined the comp-tied metric twice, and that combination corrodes the multiple-expansion path the bull case requires. The bull could still be right: MIM at $736B AUM is genuinely capital-light fee earnings the consolidated insurance multiple is undercounting, the 41% share-count reduction is a mechanical per-share tailwind, and the prior plan cleared all four 5-year commitments — a rare track record in a sector where most management teams miss. The verdict moves to Lean Long if FY26 full-year adjusted EPS prints above $10 on stable definitions with mortgage ACL flat-to-down at year-end 2026. The verdict moves to Avoid if a third Q4 redefinition appears, FY26 adjusted EPS comes in below $9.50, or year-end 2026 ACL crosses $1.2B.